Alecta claims more than EUR 134m from Novo Nordisk, which has been charged with financial market manipulation

The Swedish pension fund claims more than EUR 134m in compensation from Novo Nordisk, making it responsible for the single largest claim in the Danish legal case against the company charged with financial market manipulation.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
BY KEVIN GRØNNEMANN, MEDWATCH

One Swedish pension fund stands out in the sizeable crowd of investors claiming compensation from Novo Nordisk in a Danish legal case of financial market manipulation.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading